We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
European amino acid manufacturers feeling the pinch from cheaper Chinese imports should consider entering into joint ventures in Asia, advises Frost and Sullivan, since manufacturing costs are lower but quality is still high.
Israeli drugmaker BiolineRx has signed a licensing agreement with Gevys Pharmaceuticals for the development and commercialization of a novel approach for the treatment of acute and chronic pain.
A study released by the Centers for Disease Control (CDC) finds that patients taking stimulants for attention deficit hyperactivity disorder (ADHD) are making frequent trips to the emergency room amid a growing debate over the drugs' labeling.
Germany-based Schering AG has launched two new Phase II clinical studies in the U.S. and Canada evaluating its novel epothilone, ZK-EPO, for the treatment of metastatic breast cancer and recurrent ovarian cancer.
Japan-based AnGes has signed a collaboration agreement with U.S. company Vical for Allovectin-7, Vical's proprietary immunotherapeutic for malignant melanoma.
In the Daily International Pharma Alert dated May 25, Predix Pharmaceuticals was incorrectly identified as an Israeli company. While the company has offices is Israel, it is based in Lexington, Mass.
Only one child in 20 who needs HIV treatment receives it, according to a report launched today by seven of the world's leading child advocacy organizations.
A new drug discovery approach, which essentially reverses the process of drug compound screening promises a increased efficiency in drug discovery whilst keeping costs down to a minimum.
A pharmaceutical company in Uganda has manufactured a new malaria drug to help in the fight against malaria, the leading killer disease in some parts of Africa.